EcoDrugPlus

Interleukin-8-Like

Ensembl ID : ENSSLDG00000024899
Gene Symbol: LOC111664505
3 Cross references
183 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSSLDG00000022325
Gene Symbol: LOC111657766
2 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSLDG00000020025
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSSLDG00000000816
Gene Symbol: IDH2
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSSLDG00000003354
Gene Symbol: LOC111659144
3 Cross references
186 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSSLDG00000023997
Gene Symbol: LOC111651710
3 Cross references
191 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSSLDG00000023620
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSSLDG00000009485
Gene Symbol: KDR
3 Cross references
196 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSSLDG00000024283
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSLDG00000016633
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSLDG00000005617
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSLDG00000005815
Gene Symbol: LOC111661738
3 Cross references
142 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).